DOXORUBICIN RETENTION AND CHEMORESISTANCE IN HUMAN MESOTHELIOMA CELL-LINES

Citation
H. Isobe et al., DOXORUBICIN RETENTION AND CHEMORESISTANCE IN HUMAN MESOTHELIOMA CELL-LINES, International journal of cancer, 57(4), 1994, pp. 581-585
Citations number
26
Categorie Soggetti
Oncology
ISSN journal
00207136
Volume
57
Issue
4
Year of publication
1994
Pages
581 - 585
Database
ISI
SICI code
0020-7136(1994)57:4<581:DRACIH>2.0.ZU;2-8
Abstract
Eight cell lines were established from the pleural effusion of 4 patie nts with malignant mesothelioma. The most sensitive (FCCMES-4) and the most resistant (FCCMES-2) mesothelioma cell lines had IC50 of 0.66 an d 1.85 mu M for doxorubicin in clonogenic assays, respectively. In com parison with murine leukemic P388 cells, mesothelioma cell lines were 7.5- to 21-fold more resistant to doxorubicin. Co-incubation with vera pamil significantly increased doxorubicin retention in one of the cell lines (FCCMES-2) expressing P-glycoprotein in 16.8% of the cells. The se results indicate that doxorubicin resistance may be intrinsic in re fractory mesothelioma patients and P-glycoprotein-mediated drug efflux may be involved in resistance of some of the mesotheliomas. (C) 1994 Wiley-Liss, Inc.